Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share (Antidilutive Securities) (Details)

v3.19.1
Net Income (Loss) Per Share (Antidilutive Securities) (Details) - shares
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 12,054,233 2,760,876
Stock options    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 1,768,350 9,045
Unvested restricted stock units and awards    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 2,022,057 8,510
Warrants    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 470,000 0
Convertible Notes    
Common share equivalents for securities that were anti-dilutive and therefore excluded from the computation of diluted earnings per share    
Anti-dilutive securities excluded from computation of diluted loss per share (in shares) 7,793,826 2,743,321